Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.
暂无分享,去创建一个
R. Cardiff | Shunyou Wang | Hong Wu | C. Abate-Shen | Mei Cao | G. Cunha | P. Romanienko | Whitney A. Banach-Petrosky | S. Couto | Paulo C. Duarte
[1] A. Balmain,et al. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice , 2007, Nature.
[2] R. DiPaola,et al. Vitamin D Inhibits the Formation of Prostatic Intraepithelial Neoplasia in Nkx3.1; Pten Mutant Mice , 2006, Clinical Cancer Research.
[3] W. Gerald,et al. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer , 2006, Proceedings of the National Academy of Sciences.
[4] Shunyou Wang,et al. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[5] Robert D. Cardiff,et al. Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.
[6] E. Tokunaga,et al. Genetic mutual relationship between PTEN and p53 in gastric cancer. , 2005, Cancer letters.
[7] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[8] Jingxia Li,et al. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation. , 2005, Cancer research.
[9] P. Pandolfi,et al. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. , 2005, Genes & development.
[10] A. Levine,et al. The coordinate regulation of the p53 and mTOR pathways in cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] T. Tsuruo. Tumorigenesis facilitated by Pten deficiency in the skin: evidence of p53-Pten complex formation on the initiation phase. , 2005, Cancer Science.
[12] M. Rubin,et al. Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee , 2004, Cancer Research.
[13] A. Balmain,et al. Genetic interactions between Pten and p53 in radiation-induced lymphoma development , 2003, Oncogene.
[14] P. Pandolfi,et al. Pten Dose Dictates Cancer Progression in the Prostate , 2003, PLoS biology.
[15] Hua-Chuan Zheng,et al. Role of PTEN and MMP‐7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma , 2003, Pathology international.
[16] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[17] H. Hanafusa,et al. PTEN Induces Cell Cycle Arrest by Decreasing the Level and Nuclear Localization of Cyclin D1 , 2003, Molecular and Cellular Biology.
[18] Hong Wu,et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. , 2003, Cancer cell.
[19] Pier Paolo Pandolfi,et al. PTEN and p53: who will get the upper hand? , 2003, Cancer cell.
[20] Jose J. Galvez,et al. Prostatic intraepithelial neoplasia in genetically engineered mice. , 2002, The American journal of pathology.
[21] T. Liu,et al. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. , 2002, Biochemical and biophysical research communications.
[22] R. Cardiff,et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Dixon,et al. PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy* , 2002, The Journal of Biological Chemistry.
[24] M. Ittmann,et al. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Mak,et al. Regulation of PTEN transcription by p53. , 2001, Molecular cell.
[26] R. Mamillapalli,et al. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2 , 2001, Current Biology.
[27] P. Pandolfi,et al. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse , 2001, Nature Genetics.
[28] J. Gustafsson,et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. , 2001, Developmental biology.
[29] R. Cardiff,et al. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. , 2000, Cancer research.
[30] T. Mak,et al. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. , 2000, Cancer research.
[31] Jerilyn A. Walker,et al. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). , 2000, BioTechniques.
[32] Domenico Coppola,et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer , 2000, Oncogene.
[33] H. Wu,et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Costa-Pereira,et al. Molecular and cellular biology of prostate cancer—the role of apoptosis as a target for therapy , 1999, Prostate Cancer and Prostatic Diseases.
[35] C. Cordon-Cardo,et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] Hong Sun,et al. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Deitch,et al. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors , 1998, Cancer.
[38] Carlos Cordon-Cardo,et al. Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.
[39] M. Ittmann,et al. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[40] W. Isaacs,et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. , 1998, Cancer research.
[41] J. Herman,et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. , 1997, Cancer research.
[42] W. Isaacs,et al. Relation between aberrant α‐catenin expression and loss of E‐cadherin function in prostate cancer , 1997, International journal of cancer.
[43] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[44] G. Cunha,et al. Induction of prostatic morphology and secretion in urothelium by seminal vesicle mesenchyme. , 1995, Development.
[45] W. Isaacs,et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. , 1994, Cancer research.
[46] R. deVere White,et al. p53 in prostate cancer: frequent expressed transition mutations. , 1994, Journal of the National Cancer Institute.
[47] S. Hilsenbeck,et al. p53 is mutated in a subset of advanced-stage prostate cancers. , 1993, Cancer research.
[48] W. Isaacs,et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.
[49] G. Cunha,et al. Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate. , 1986, Biology of reproduction.
[50] R. Cardiff,et al. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. , 2008, The American journal of pathology.
[51] E. Gelmann,et al. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network. , 1997, Journal of the National Cancer Institute.
[52] R. Bookstein. Tumor suppressor genes in prostatic oncogenesis. , 1994, Journal of cellular biochemistry. Supplement.
[53] G. Cunha,et al. Mesenchymal-epithelial interactions: technical considerations. , 1987, Progress in clinical and biological research.